Apr 24, 2018
This episode discusses how RNA interference and CRISPR/Cas9 technologies are helping to build better mouse models and push drug discovery into a new era.
Most, if not all, consumers are feeling the weight of rising drug costs. But while much of the controversy surrounding rising drug prices has focused on a handful of pharmaceutical companies that have snapped up old drugs and then aggressively raised prices, the fact is that drug prices are far more likely to further increase due to the volume of candidates that falter in late-stage efficacy studies and the fact that there is no more low-hanging fruit.
The article was written by Dr Prem Premsrirut, who is Founder and Chief Executive Officer of Mirimus
If you'd like to view the original article then follow the link below:
You can also download the original article pdf here:
For more information on Drug Discovery World, head to: